StockNews.AI
APH
StockNews.AI
182 days

HealthEdge Announces Successful Sale of LifeSync to Amphenol

1. LifeSync was acquired by Amphenol, strengthening its healthcare product offerings. 2. LifeSync's revenue grew from $5 million to $100 million under HealthEdge's management. 3. Amphenol expands its market presence, likely enhancing APH's growth potential. 4. Investment returns for HealthEdge underline LifeSync's successful evolution. 5. LifeSync specializes in patient monitoring devices, important for healthcare settings.

6m saved
Insight
Article

FAQ

Why Bullish?

The acquisition enhances Amphenol's portfolio, suggesting positive growth for APH. Similar past acquisitions have boosted stock performance significantly.

How important is it?

The acquisition is pivotal for Amphenol's strategy within healthcare, likely impacting APH positively.

Why Long Term?

Amphenol's strategy of integrating LifeSync indicates sustained growth potential. Historically, such long-term strategies yield better returns as markets mature.

Related Companies

APHHLTH
, /PRNewswire/ -- HealthEdge Investment Partners, LLC ("HealthEdge"), a lower middle market private equity fund focused on healthcare, announced today that it has completed the sale of LifeSync ("LifeSync" or the "Company"), a developer, manufacturer, and marketer of disposable and reusable patient monitoring devices and connections sold to hospitals and other high acuity settings. LifeSync was acquired by Amphenol (NYSE: APH), one of the world's largest providers of connectors, interconnect systems, antennas, sensors and specialty cable. "When we first invested in LifeSync, our objective was to grow revenues and scale an entrepreneurial business with a great product and unique IP," said Brian Anderson, Managing Partner of HealthEdge. "We accomplished our goals and more by appointing a new management team, completing four acquisitions that added complementary products and vertically integrated manufacturing, and reorganizing the company into its neuro, cardio, and contract manufacturing divisions. In the process, LifeSync touched millions of patients with its products, and grew revenues from $5 million to approximately $100 million. Given the strong organic and acquisitive growth of the Company, this exit yielded strong investment returns for HealthEdge Fund II." "I am proud of the growth LifeSync has accomplished and the work our global team does each day to provide critical medical products to hospitals," added Bob Buehler, General Manager of LifeSync. "HealthEdge has been an invaluable partner to LifeSync as the Company has evolved during my tenure as CEO. We are excited to join Amphenol and work on the Company's future growth plans." Hill Ward Henderson acted as legal counsel and Lincoln International LLC served as financial advisor to LifeSync on the sale. ABOUT HEALTHEDGE HealthEdge Investment Partners, LLC is an operating-oriented private equity firm founded in 2005 that focuses exclusively on the healthcare industry. HealthEdge seeks to achieve superior returns by investing in businesses that benefit from the knowledge, experience, and network of relationships of its partners. HealthEdge's partners have more than 100 years of combined experience in healthcare as operators and investors. For more information on HealthEdge, please visit www.healthedgepartners.com. ABOUT LIFESYNC LifeSync is the only vertically integrated company focused solely on patient connections, providing cardiac cables, leadwires and neuromonitoring connections in addition to contract manufacturing solutions. Headquartered in Coral Springs, FL, LifeSync develops and manufactures products at its state-of-the-art manufacturing capabilities. ABOUT AMPHENOL Amphenol Corporation is one of the world's largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable.  Amphenol designs, manufactures and assembles its products at facilities in approximately 40 countries around the world and sells its products through its own global sales force, independent representatives and a global network of electronics distributors.  Amphenol has a diversified presence as a leader in high-growth areas of the interconnect market including: Automotive, Commercial Aerospace, Communications Networks, Defense, Industrial, Information Technology and Data Communications and Mobile Devices. For more information, visit www.amphenol.com. CONTACT:HealthEdge Investment Partners, LLC5550 W. Executive Drive, Suite 230Tampa, Florida 33609(813) 490-7100www.healthedgepartners.com SOURCE HealthEdge Investment Partners, LLC WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News